BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9861440)

  • 21. Interleukin-6-type cytokine-induced changes in acute phase protein glycosylation.
    Van Dijk W; Mackiewicz A
    Ann N Y Acad Sci; 1995 Jul; 762():319-30. PubMed ID: 7545370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?
    Alenius GM; Eriksson C; Rantapää Dahlqvist S
    Clin Exp Rheumatol; 2009; 27(1):120-3. PubMed ID: 19327240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides.
    Pawlaczyk M; Sobieska M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):107-12. PubMed ID: 17053844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD44-isoform variant-5 (sCD44v5) in psoriatic arthritis.
    Haberhauer G; Kittl EM; Bauer K; Skoumal M; Feyertag J; Dunky A
    Clin Exp Rheumatol; 1998; 16(6):766-7. PubMed ID: 9844784
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A.
    Macchioni P; Boiardi L; Cremonesi T; Battistel B; Casadei-Maldini M; Beltrandi E; Mancini R; Salvarani C
    Rheumatol Int; 1998; 18(1):27-33. PubMed ID: 9672996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon beta 2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines.
    Mackiewicz A; Kushner I
    Scand J Immunol; 1989 Mar; 29(3):265-71. PubMed ID: 2470133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
    Chodorowska G; Czelej D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis.
    Helliwell PS; Marchesoni A; Peters M; Platt R; Wright V
    Ann Rheum Dis; 1991 Jun; 50(6):362-5. PubMed ID: 2059079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified immunoglobulin G glycosylation pattern during turpentine-induced acute inflammation in rats.
    Canellada A; Margni RA
    Medicina (B Aires); 2002; 62(3):249-55. PubMed ID: 12150009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levels of soluble receptors for interleukin-2 in the serum of patients with rheumatoid arthritis].
    Pavelka K
    Cas Lek Cesk; 1990 Dec; 129(50):1582-5. PubMed ID: 2272075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression and glycosylation of plasma proteins in rheumatoid arthritis.
    Raghav SK; Gupta B; Agrawal C; Saroha A; Das RH; Chaturvedi VP; Das HR
    Glycoconj J; 2006 May; 23(3-4):167-73. PubMed ID: 16691500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of concanavalin A-enzyme immunosorbent assay for glycated haptoglobin using polyclonal and monoclonal antibodies.
    Katnik I; Dobryszycka W
    J Immunoassay; 1992; 13(2):145-62. PubMed ID: 1430237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration?
    Hrycaj P; Sobieska M; Mackiewicz S; Müller W
    Ann Rheum Dis; 1993 Feb; 52(2):138-41. PubMed ID: 8447693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit.
    Saso L; Silvestrini B; Zwain I; Guglielmotti A; Luparini MR; Cioli V; Cheng CY
    J Rheumatol; 1992 Dec; 19(12):1859-67. PubMed ID: 1284132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble interleukin-2 receptors in children with juvenile chronic arthritis.
    Fassbender K; Michels H; Vogt P; Aeschlimann A; Müller W
    Scand J Rheumatol; 1992; 21(3):120-3. PubMed ID: 1376493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.
    Olewicz-Gawlik A; Korczowska-Łacka I; Łacki JK; Klama K; Hrycaj P
    Clin Rheumatol; 2007 Oct; 26(10):1679-84. PubMed ID: 17310270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
    Czelej D; Chodorowska G; Lechowska-Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.